Alpha Biologics Sdn Bhd (ABSB) Release: UK Bioprocess Development Labs Open for Business
Published: Nov 12, 2010
The company recently completed building an $18m manufacturing plant in Penang, Malaysia for the cGMP production of mammalian cell proteins. Now, in a further step, it has opened new UK labs designed to provide customers with services at earlier stages of the manufacturing process. These range from R&D and bioprocess development through to scale-up and optimisation of the biomanufacturing process.
The new laboratories are based within Babraham’s new, ultra-modern Maia biomedical complex. Michelle Peake, Alpha’s COO said: “Our key focus is on the manufacture of monoclonal antibodies and recombinant proteins - though clients may sometimes want whole cells, membrane fractions or other specified products. The UK labs have been designed to be flexible, so they can cope with any of these needs - they will suit researchers just starting to develop a biomanufacturing process all the way through to those preparing clinical trial materials".
"Once bioprocesses are optimised, they are transferred elsewhere for full-scale manufacture - that can either be at our own cGMP manufacturing plant, or other sites chosen by our clients”.
The new UK facility will be run by the company's Director of Process Development & Manufacturing, Mark Doran, who said: “We provide the full spectrum of biomanufacturing services including upstream process development, downstream protein purification and cell banking, too. If clients then wish to proceed to full-scale cGMP production, we can do that too.”
"The whole point is to create the best production process, shorten the product development cycle and increase productivity. Recently we were able to quadruple the yield of a particular product just by developing a better separation process, resulting in significant cost savings for our client".
Obtain further information from:
Mark Doran Tel: 01223 496070
Ian Robson Tel: 0191 487 5961
Alpha Biologics (www.alphabiologics.com) is an independent, privately owned company with R&D and production facilities in the UK and Malaysia. The two main operating bases are R&D and bioprocess development laboratories located on the Babraham Research Campus, Cambridge, at the heart of the UK's biotechnology industry and a 5,000 sq metre advanced cGMP biomanufacturing facility for mammalian cell proteins on the Penang Science Park, Malaysia.